Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.

[1]  Hegang Chen,et al.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. , 2006, Journal of the National Medical Association.

[2]  C. Bloomfield,et al.  NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  B. Haward,et al.  Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis , 1999, The Lancet.

[4]  R. Berardi,et al.  The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  M. Miyazaki,et al.  Hepatic resection for colorectal metastases , 1999, Diseases of the colon and rectum.

[6]  D. Dempsey Survival After Hepatic Resection of Colorectal Cancer Metastases: A National Experience , 2009 .

[7]  R. McLeod,et al.  Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  M. Choti,et al.  Peri‐operative chemotherapy for resectable colorectal liver metastasis: Does timing of systemic therapy matter? , 2012, Journal of surgical oncology.

[9]  R. Parks,et al.  Surgery for Colorectal Liver Metastases , 2013, Digestive Surgery.

[10]  P. Loehrer Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure , 2008 .

[11]  Shou-Dong Lee,et al.  Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias? , 2007, Scandinavian journal of gastroenterology.

[12]  J. Hardcastle,et al.  DELAY IN DIAGNOSIS AND TREATMENT OF SYMPTOMATIC COLORECTAL CANCER , 1979, The Lancet.

[13]  G. Cooper,et al.  Survival after hepatic resection in metastatic colorectal cancer , 2007, Cancer.

[14]  K. Croome,et al.  Increasing time delay from presentation until surgical referral for hepatobiliary malignancies. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  D. Al-azawi,et al.  Referral patterns of patients with liver metastases due to colorectal cancer for resection , 2008, International Journal of Colorectal Disease.

[16]  J. Wardle,et al.  Rethinking diagnostic delay in cancer: how difficult is the diagnosis? , 2014, BMJ : British Medical Journal.

[17]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[18]  K. Helzlsouer,et al.  Delay in breast cancer: a review of the literature. , 1992, Public health reviews.

[19]  D. Siegmund,et al.  Maximally Selected Chi Square Statistics , 1982 .

[20]  H. Kennecke,et al.  Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC) , 2010, Annals of Surgical Oncology.

[21]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[23]  N. Kemeny,et al.  Role of adjuvant therapy after resection of colorectal cancer liver metastases. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[25]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[26]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[27]  S. Aggestrup,et al.  The impact of delayed diagnosis of lung cancer on the stage at the time of operation. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  M. Choti,et al.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors , 2012, Clinical epidemiology.

[29]  G. Brandi,et al.  Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. , 2006, Cancer treatment reviews.

[30]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[31]  L. Sarli,et al.  Delay in the diagnosis and outcome of colorectal cancer: a prospective study. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  P. Donnan,et al.  Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas , 2004, British Journal of Cancer.

[33]  M. Choti,et al.  Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making , 2012, Annals of Surgical Oncology.

[34]  C. Young,et al.  Implications of delayed diagnosis in colorectal cancer. , 2000, The Australian and New Zealand journal of surgery.

[35]  A. Coates Breast cancer: delays, dilemmas, and delusions , 1999, The Lancet.

[36]  P. Colombo,et al.  Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases? , 2010, Annals of surgery.